Prieto-Centurion Valentin, Rolle Andrew J, Au David H, Carson Shannon S, Henderson Ashley G, Lee Todd A, Lindenauer Peter K, McBurnie Mary A, Mularski Richard A, Naureckas Edward T, Vollmer William M, Joese Binoy J, Krishnan Jerry A
1 Division of Pulmonary, Critical Care, Sleep and Allergy and.
Am J Respir Crit Care Med. 2014 Nov 1;190(9):989-95. doi: 10.1164/rccm.201406-1166OC.
Clinical trials in chronic obstructive pulmonary disease (COPD) usually require evidence of airflow obstruction and clinical risk factors. International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes or patient-reported physician diagnoses are often used for epidemiologic studies and performance improvement programs.
To evaluate agreement between these case definitions for COPD and to assess the comparability of study populations identified as having COPD not using the clinical trial reference standard.
We recruited patients from the COPD Outcomes-based Network for Clinical Effectiveness and Research Translation multicenter clinical registry in a cross-sectional study. Demographics, clinical, and post-bronchodilator spirometry data were collected at an in-person study visit. The kappa statistic (κ) was used to evaluate agreement. A multivariable logistic regression model was used to identify patient characteristics associated with meeting the trial reference standard.
A total of 998 (82.8%) of 1,206 study participants met at least one case definition for COPD (of the 998: 91% using ICD-9 codes, 73% using patient-reported physician diagnosis, 56% using trial reference standard); agreement between case definitions was poor (κ = 0.20-0.26). Lack of airflow obstruction was the principal (89%) reason patients identified as having COPD did not meet the trial reference standard. Patients who were black (vs. white), obese (vs. normal weight), or had depression (vs. not) were less likely to meet the trial reference standard (odds ratio [95% CI], 0.37 [0.26-0.53], 0.51 [0.34-0.75], 0.53 [0.40-0.71], respectively).
Findings highlight concerns about the applicability of findings in clinical trials to patients meeting other case definitions for COPD.
慢性阻塞性肺疾病(COPD)的临床试验通常需要气流阻塞和临床风险因素的证据。国际疾病分类第九版(ICD - 9)诊断编码或患者报告的医生诊断常用于流行病学研究和绩效改进项目。
评估这些COPD病例定义之间的一致性,并评估未使用临床试验参考标准而被确定为患有COPD的研究人群的可比性。
在一项横断面研究中,我们从COPD基于结局的临床有效性和研究转化多中心临床登记处招募患者。在亲自进行的研究访视中收集人口统计学、临床和支气管扩张剂后肺功能数据。kappa统计量(κ)用于评估一致性。使用多变量逻辑回归模型来确定与符合试验参考标准相关的患者特征。
1206名研究参与者中有998名(82.8%)至少符合一种COPD病例定义(在这998名中:91%使用ICD - 9编码,73%使用患者报告的医生诊断,56%使用试验参考标准);病例定义之间的一致性较差(κ = 0.20 - 0.26)。气流阻塞不足是被确定为患有COPD的患者未达到试验参考标准的主要(89%)原因。黑人(与白人相比)、肥胖(与正常体重相比)或患有抑郁症(与未患抑郁症相比)的患者达到试验参考标准的可能性较小(优势比[95%置信区间]分别为0.37[0.26 - 0.53]、0.51[0.34 - 0.75]、0.53[0.40 - 0.71])。
研究结果凸显了对临床试验结果适用于符合其他COPD病例定义的患者的担忧。